Health Catalyst Profit Margin

The latest profit margin for HCAT is -90.61% as of June 2026. That compares with -31.67% in the prior-year period — down 186.1% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Health Catalyst's historical trend and sector peers before judging valuation or financial health.

Over the past year, HCAT's profit margin moved from -31.67% to -90.61% — a 186.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Health Catalyst's valuation or profitability profile.

Against Healthcare companies, HCAT currently prints -90.61% for profit margin, while the sector average sits near 21.34%. That is roughly 524.7% below the sector mean. Large gaps often invite a closer look at Health Catalyst's growth, margins, and balance sheet.

Profit Margin shows how effectively Health Catalyst converts resources into returns. At -90.61%, HCAT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -31.67% in the prior-year period — down 186.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting HCAT's profit margin (-90.61%), review year-over-year change from -31.67%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.